18258852|t|Amyloid activates GSK-3beta to aggravate neuronal tauopathy in bigenic mice.
18258852|a|The hypothesis that amyloid pathology precedes and induces the tau pathology of Alzheimer's disease is experimentally supported here through the identification of GSK-3 isozymes as a major link in the signaling pathway from amyloid to tau pathology. This study compares two novel bigenic mouse models: APP-V717I x Tau-P301L mice with combined amyloid and tau pathology and GSK-3beta x Tau-P301L mice with tauopathy only. Extensive and remarkable parallels were observed between these strains including 1) aggravation of tauopathy with highly fibrillar tangles in the hippocampus and cortex; 2) prolonged survival correlated to alleviated brainstem tauopathy; 3) development of severe cognitive and behavioral defects in young adults before the onset of amyloid deposition or tauopathy; and 4) presence of pathological phospho-epitopes of tau, including the characteristic GSK-3beta motif at S396/S404. Both GSK-3 isozymes were activated in the brain of parental APP-V717I amyloid mice, even at a young age when cognitive and behavioral defects are evident but before amyloid deposition. The data indicate that amyloid induces tauopathy through activation of GSK-3 and suggest a role for the kinase in maintaining the functional integrity of adult neurons.
18258852	18	27	GSK-3beta	Gene	56637
18258852	41	59	neuronal tauopathy	Disease	MESH:D024801
18258852	71	75	mice	Species	10090
18258852	97	114	amyloid pathology	Disease	MESH:C000718787
18258852	157	176	Alzheimer's disease	Disease	MESH:D000544
18258852	240	245	GSK-3	Gene	56637
18258852	301	308	amyloid	Disease	MESH:C000718787
18258852	365	370	mouse	Species	10090
18258852	383	388	V717I	ProteinMutation	tmVar:p|SUB|V|717|I;HGVS:p.V717I;VariantGroup:0;OriginalGene:56637;CorrespondingGene:2932;CorrespondingSpecies:10090
18258852	395	400	P301L	ProteinMutation	tmVar:p|SUB|P|301|L;HGVS:p.P301L;VariantGroup:1;OriginalGene:56637;CorrespondingGene:2932;CorrespondingSpecies:10090
18258852	401	405	mice	Species	10090
18258852	420	427	amyloid	Disease	MESH:C000718787
18258852	450	459	GSK-3beta	Gene	56637
18258852	466	471	P301L	ProteinMutation	tmVar:p|SUB|P|301|L;HGVS:p.P301L;VariantGroup:1;OriginalGene:56637;CorrespondingGene:2932;CorrespondingSpecies:10090
18258852	472	476	mice	Species	10090
18258852	482	491	tauopathy	Disease	MESH:D024801
18258852	597	606	tauopathy	Disease	MESH:D024801
18258852	725	734	tauopathy	Disease	MESH:D024801
18258852	761	793	cognitive and behavioral defects	Disease	MESH:D003072
18258852	830	848	amyloid deposition	Disease	MESH:D058225
18258852	852	861	tauopathy	Disease	MESH:D024801
18258852	949	958	GSK-3beta	Gene	56637
18258852	984	989	GSK-3	Gene	56637
18258852	1043	1048	V717I	ProteinMutation	tmVar:p|SUB|V|717|I;HGVS:p.V717I;VariantGroup:0;OriginalGene:56637;CorrespondingGene:2932;CorrespondingSpecies:10090
18258852	1049	1056	amyloid	Disease	MESH:C000718787
18258852	1057	1061	mice	Species	10090
18258852	1088	1120	cognitive and behavioral defects	Disease	MESH:D003072
18258852	1144	1162	amyloid deposition	Disease	MESH:D058225
18258852	1187	1194	amyloid	Disease	MESH:C000718787
18258852	1203	1212	tauopathy	Disease	MESH:D024801
18258852	1235	1240	GSK-3	Gene	56637
18258852	Positive_Correlation	MESH:C000718787	56637
18258852	Association	MESH:D024801	HGVS:p.P301L;CorrespondingGene:2932
18258852	Association	MESH:D024801	56637
18258852	Association	MESH:C000718787	HGVS:p.V717I;CorrespondingGene:2932
18258852	Association	MESH:D024801	HGVS:p.V717I;CorrespondingGene:2932
18258852	Association	MESH:D003072	56637
18258852	Association	MESH:D024801	2932
18258852	Association	MESH:C000718787	2932

